Seeking to Stop “Foreign Freeloaders,” CMS Proposes Revised Pricing for Part B Drugs Based on International Prices
[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]Following the release of an HHS report on international drug pricing, President Trump announced a new Department of Health and Human Services (HHS) initiative to index…
Read more